Literature DB >> 31270686

Managing Chronic Non-Malignant Pain in the Elderly: Intrathecal Therapy.

Barbara Kleinmann1, Tilman Wolter2.   

Abstract

Intrathecal drug delivery (IDD) was first described in 1981 by Onofrio, who used a pump for continuous and intrathecal delivery of morphine to treat cancer pain. Over the following four decades, many reports supported this treatment method with implanted pumps for cancer and non-cancer pain. To date, more than 300,000 pumps for pain therapy and spasticity have been implanted worldwide. This article reviews current knowledge regarding intrathecal opioid therapy, focusing particularly on the use of IDD in elderly patients. Current literature is presented, and the arguments in favor of and against this therapy in elderly patients are discussed.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31270686     DOI: 10.1007/s40266-019-00692-7

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  105 in total

1.  [Treatment of post-herpes zoster pain with tramadol. Results of an open pilot study versus clomipramine with or without levomepromazine].

Authors:  H Göbel; T Stadler
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 2.  Do the potential benefits outweigh the risks? An update on the use of ziconotide in clinical practice.

Authors:  E Bäckryd
Journal:  Eur J Pain       Date:  2018-04-25       Impact factor: 3.931

3.  Hypogonadism in patients treated with intrathecal morphine.

Authors:  P M Finch; L J Roberts; L Price; N C Hadlow; P T Pullan
Journal:  Clin J Pain       Date:  2000-09       Impact factor: 3.442

4.  Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.

Authors:  Maged Hamza; Daniel Doleys; Mary Wells; Jackie Weisbein; Jeremy Hoff; Michelle Martin; Costa Soteropoulos; Jose Barreto; Steven Deschner; Jessica Ketchum
Journal:  Pain Med       Date:  2012-07-30       Impact factor: 3.750

5.  Age, pain intensity, and opioid dose in patients with advanced cancer.

Authors:  A Viganó; E Bruera; M E Suarez-Almazor
Journal:  Cancer       Date:  1998-09-15       Impact factor: 6.860

6.  Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.

Authors:  Pradermchai Kongkam; Dennis L Wagner; Stuart Sherman; Evan L Fogel; Stephanie C Whittaker; James L Watkins; Lee McHenry; Glen A Lehman
Journal:  Am J Gastroenterol       Date:  2009-04-14       Impact factor: 10.864

7.  Accuracy and efficacy of intrathecal administration of morphine sulfate for treatment of intractable pain using the Prometra(®) Programmable Pump.

Authors:  Richard Rauck; Timothy Deer; Steve Rosen; Gurpreet Padda; John Barsa; Elmer Dunbar; Gopala Dwarakanath
Journal:  Neuromodulation       Date:  2009-11-20

8.  A Prospective, Randomized Trial of Intrathecal Injection vs. Epidural Infusion in the Selection of Patients for Continuous Intrathecal Opioid Therapy.

Authors:  Valerie C Anderson; Kim J Burchiel; Beverly Cooke
Journal:  Neuromodulation       Date:  2003-07

9.  EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research.

Authors:  L J Seppala; N van der Velde; T Masud; H Blain; M Petrovic; T J van der Cammen; K Szczerbińska; S Hartikainen; R A Kenny; J Ryg; P Eklund; E Topinková; A Mair; L Laflamme; H Thaler; G Bahat; M Gutiérrez-Valencia; M A Caballero-Mora; F Landi; M H Emmelot-Vonk; A Cherubini; J P Baeyens; A Correa-Pérez; A Gudmundsson; A Marengoni; D O'Mahony; N Parekh; F E Pisa; C Rajkumar; M Wehling; G Ziere
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

10.  Continuous intrathecal morphine administration for cancer pain management using an intrathecal catheter connected to a subcutaneous injection port: a retrospective analysis of 22 terminal cancer patients in korean population.

Authors:  Jong Hae Kim; Jin Yong Jung; Min Soo Cho
Journal:  Korean J Pain       Date:  2013-01-04
View more
  1 in total

1.  Intrathecal Morphine Infusion Therapy via a Percutaneous Port for Refractory Cancer Pain in China: An Efficacy, Safety and Cost Utilization Analysis.

Authors:  Wangjun Qin; Yifan Li; Botao Liu; Ying Liu; Yi Zhang; Xianglin Zhang; Pengmei Li; Bifa Fan
Journal:  J Pain Res       Date:  2020-01-23       Impact factor: 3.133

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.